An Examination on Detected Condition of Extended-spectrum β-Lactamase-producing Organisms
スポンサーリンク
概要
- 論文の詳細を見る
Between April 2006 and March 2009, research into extended-spectrum β-lactamase (hereafter ESBL)-producing organisms at eight facilities in the eastern region of Hiroshima prefecture showed increases in both the number of detection and isolation rates year by year. There are also indications of a correlation between the isolation rates of ESBL-producing organisms and the antimicrobial usage density of third-generation cephem medicines. In addition, Escherichia coli accounted for 92.7% of the bacterial strains in the examination materials: urine, sputum, and stool in descending order. When the multivariate classification was analyzed after the questionnaire surveys from the eight facilities, as the isolation rates of ESBL-producing organisms exceeded 5%, it was found that more than 200 beds were provided, in addition to a bacteriological examination room, and a screening test was practiced, ICT rounds enforced, and the hospital functional evaluation had not been assessed. Through this study, it became possible to improve the detection of the ESBL-producing organisms and an opportunity was created to practice infection control at these facilities, and other neighborhood facilities based on the surveillance data. It is thought that the approach that was applied is necessary for prevention and infection control in district facilities in the future.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)